Abstract :
Liver damage caused by drugs is a serious health problem. The use of
drugs to induce liver damage in patients with liver disease can increase the risk of
liver damage. According to the Directorate General of Pharmaceutical and
Medical Devices Development (2007), Indonesia is a country with a high endemic
level regarding liver disease. This study was conducted to determine the use of
drugs that can induce liver damage in hospitalized patients with liver disease in
RSUI Kustati Surakarta. Data collection was conducted retrospectively in the
2018-2019 period from the patient's medical record. A total of 103 research
subjects are known to have the most age impaired liver function in the age range
46-55 years as many as 39 patients (37.9%), the sexes that have the most impaired
liver function are males, 65 patients (63, 1%). The most common type of liver
disorder is hepatitis, which is 66 patients (64%). The most common concomitant
disease was cholecystitis in 11 patients (10.7%). Liver-inducing drugs that are still
used are ranitidine as many as 46 patients (27.5%), ceftriaxone 35 patients (21%),
omeprazole 18 patients (10.8%), and paracetamol 11 patients (6.6%). This shows
that there are still many uses of drugs to induce liver damage that are used by
patients with impaired liver function.